News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Biome Australia.
RELATED STOCKHEAD STORIES
News
Market Highlights: Wall Street lifts after Fed’s pause; and more signs of a potential AI bubble?
Experts
MoneyTalks: Canary Capital’s Paul Hart reckons these are the biotech stocks to pop in the basket
News
Market Highlights: FDA backtracks on cannabis oil, and 5 ASX small caps to watch today
Escrow Watch
Escrow Watch: One of the top IPOs of FY22 is about release a chunk of shares
News
ASX Quarterlies: Biotechs deliver strong performances for shareholders
Experts
MoneyTalks: ASX biotechnology shares are deeply discounted – Paul Hart says ‘perfect time’ to buy
Escrow Watch
Escrow Watch: Probiotics play Biome will release nearly a third of its shares in June
Health & Biotech
ASX Health Stocks: Invion demonstrates efficacy, Biotron gets feedback from the FDA
News
Top 10 at 10: These ASX health and exploration stocks are top of the pile today
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Stockhead TV
Resolving Acne: Dermatology innovations in biotech
News
Market Highlights and 5 ASX Small Caps to watch on Monday
News
Top 10 at 10: Which ASX stocks are charging today?
IPO Watch
Weekly Small Cap and IPO Wrap: A Golden Age
IPO Watch
IPO Watch: These companies are making a late charge up the winners’ list
Health & Biotech